4DMedical Revenue and Competitors

Melbourne, Australia

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • 4DMedical's estimated annual revenue is currently $42.7M per year.(i)
  • 4DMedical's estimated revenue per employee is $251,000

Employee Data

  • 4DMedical has 170 Employees.(i)
  • 4DMedical grew their employee count by -1% last year.

4DMedical's People

NameTitleEmail/Phone
1
Founder, CEOReveal Email/Phone
2
Chief Research Officer (CRO)Reveal Email/Phone
3
VP US SalesReveal Email/Phone
4
Sr Director MarketingReveal Email/Phone
5
Regional Sales ManagerReveal Email/Phone
6
Global Manager, Medical and Clinical AffairsReveal Email/Phone
7
Clinical Product ManagerReveal Email/Phone
8
SaaS Engineering ManagerReveal Email/Phone
9
Global Manager - Medical and Clinical AffairsReveal Email/Phone
10
Systems TesterReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$182.7M52022%$124.5MN/A
#2
$33.9M135-2%N/AN/A
#3
$5.4M43-23%$20.8MN/A
#4
$14.3M5710%N/AN/A
#5
$33.4M133-13%$5MN/A
#6
$19.3M778%N/AN/A
#7
$28.4M113-3%N/AN/A
#8
$257.3M10250%N/AN/A
#9
$22.6M90-2%N/AN/A
#10
$35.9M1438%N/AN/A
Add Company

What Is 4DMedical?

Despite our rapidly increasing understanding of lung disease, our ability for effective treatments is critically limited by the lack of tools to measure lung function in a regional manner. Nearly all lung pathologies are associated at the onset of disease with subtle, significant and regional changes in airflow due to changes in tissue compliance and/or resistance. However, the current gold standard diagnostics can only measure pulmonary capacity as an average over the entire lung. As a result, a diagnosis can often come too late because for a loss of lung function to even be measurable, the disease must be well-advanced. Now, for the first time in medical history, the capacity to simply, safely and effectively view and measure regional lung function is here. We are 4DMedical - the medical technology company responsible for the XV Lung Ventilation Analysis Software - the breakthrough lung imaging technology that quantitatively measures the patterns of regional lung function in 4D.

keywords:N/A

N/A

Total Funding

170

Number of Employees

$42.7M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

4DMedical News

2022-04-20 - Pfizer bid gives lung health start-ups some air time

The boss of 4DMedical, Dr Andreas Fouras, will be travelling backwards and forwards between Australia and the US multiple times in the...

2022-04-17 - St. Joseph Hospital Announces First Commercial Use in US of ...

4DMedical (founded in 2013) changed name to 4DMedical in May 2020. 4DMedical is a medical technology company aiming to deliver the global gold...

2022-04-06 - 4DMedical (ASX:4DX) commences first clinical pilot in the United States

4D Medical is commercially using its XV LVAS™ technology for the first time in the United States. The pilot program will help open the door...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$61.7M1701%N/A
#2
$50.5M17014%N/A
#3
$54.2M17011%N/A
#4
$60.4M170-4%N/A
#5
$45M171-4%N/A